Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial.
Optimal prevention of late cytomegalovirus (CMV) disease is poorly defined. ⋯ Roche Laboratories.